Literature DB >> 12044950

Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin.

Russel J Reiter1, Dun-xian Tan, Susanne Burkhardt.   

Abstract

Cellular and organismal decline is, in part, believed to be a consequence of oxygen and nitrogen-based reactants which persistently damage macromolecules throughout a lifetime. The resulting accumulation of damaged molecules eventually seriously compromises essential functions of cells leading to their death. Excessive cellular loss causes deterioration of organ function and inevitably to the demise of the organism. The sequence of events, known as the free radical theory of aging, is widely espoused by biological gerontologists. Antioxidants are commonly employed to combat molecular damage mediated by oxygen and nitrogen-based reactants. One of these protective agents is melatonin. Melatonin has several distinct advantages as a preserver of organelle structure and function. It is widely distributed in organisms and within cells. It works via a number of mechanisms to reduce oxidative damage. Thus, melatonin scavenges a number of reactants including the hydroxyl radical (*OH), hydrogen peroxide (H(2)O(2)), nitric acid (NO*), peroxynitrite (ONOO(-)) and peroxynitrous acid (ONOOH). One of the products of melatonin's interaction with H(2)O(2), i.e., N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK), is also a highly efficient radical scavenger. The cascade of reactions where the secondary metabolites are also effective scavenges is believed to contribute to melatonin's high efficacy in reducing oxidative damage. Besides its direct scavenging actions, melatonin stimulates several antioxidative enzymes including superoxide dismutase, glutathione peroxidase and glutathione reductase in addition to inhibiting a proxidative enzyme, nitric oxide synthase. This combination of actions assists melatonin in protecting cells from the degenerative changes normally associated with aging and age-related diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044950     DOI: 10.1016/s0047-6374(01)00384-0

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  34 in total

1.  Evaluation of blood antioxidant defense and apoptosis in peripheral lymphocytes on exogenous administration of pineal proteins and melatonin in rats.

Authors:  Vijay K Bharti; R S Srivastava; J K Malik; D Warren Spence; S R Pandi-Perumal; Gregory M Brown
Journal:  J Physiol Biochem       Date:  2011-12-29       Impact factor: 4.158

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 3.  Melatonin and nitric oxide.

Authors:  S Aydogan; M Betul Yerer; A Goktas
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

4.  Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes.

Authors:  Wei Chen; Hui Cao; Qian-Yi Lu; Na Wang; Shu-Zhi Zhao; Xun Xu; Zhi Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 5.  Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy.

Authors:  Burkhard Poeggeler
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 6.  Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

Authors:  Rüdiger Hardeland
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 7.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 8.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

9.  Influence of oryzanol and ferulic Acid on the lipid metabolism and antioxidative status in high fat-fed mice.

Authors:  Myoung Jin Son; Catherine W Rico; Seok Hyun Nam; Mi Young Kang
Journal:  J Clin Biochem Nutr       Date:  2010-02-27       Impact factor: 3.114

10.  Does melatonin ameliorate neurological changes associated with Alzheimer's disease in ovariectomized rat model?

Authors:  Hanaa H Ahmed; Selim F Estefan; Ehab M Mohamd; Abd El-Razik H Farrag; Rania S Salah
Journal:  Indian J Clin Biochem       Date:  2012-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.